Merck | MRK - Current Assets



Merck reported EUR12.2B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Adidas EUR 11.23B 287M Jun/2025
Adyen EUR 10.89B 1.34B Dec/2024
Akzo Nobel EUR 6.33B 194M Jun/2025
Alcon AG USD 6.31B 239M Jun/2025
Amadeus IT EUR 2.8B 236.9M Jun/2025
Amarin USD 573.06M 22.34M Mar/2025
AstraZeneca USD 28.94B 2.8B Jun/2025
BASF EUR 31.9B 1.29B Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Beiersdorf EUR 6.65B 212M Jun/2025
Covestro EUR 5.64B 648M Jun/2025
Danone EUR 12.9B 111M Jun/2025
Fresenius EUR 10.88B 1.03B Jun/2025
Fresenius Medical Care EUR 8.14B 178.09M Jun/2025
Galapagos EUR 3.26B 217.04M Jun/2025
Genmab DKK 3.91B 127M Jun/2025
Givaudan CHF 4.24B 629M Jun/2024
GlaxoSmithKline GBP 17.67B 412M Jun/2025
GRIFOLS EUR 5.25B 393.8M Jun/2025
Henkel EUR 10.34B 693M Jun/2025
Hikma Pharmaceutical USD 2.26B 22M Dec/2024
Infineon EUR 9.64B 32M Jun/2025
Linde USD 13.63B 682M Jun/2025
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.2B 216M Jun/2025
Novartis USD 25.94B 831M Jun/2025
Philips EUR 9.06B 394M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sanofi 37.02B 7B Jun/2025
UCB EUR 4.79B 1.47B Dec/2024